FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Publications
  • Links
  • News
✕
Published by Austin on March 15, 2022
Categories
  • DateMarch 15, 2022
  • Executive Board
  • Research Groups
  • Central Projects
  • Associated projects
  • Alumni

Curriculum Vitae

PD Dr. med. Lebriz Altay, FEBO

Department of Ophthalmology
University of Cologne
Kerpener Straße 62
50937 Cologne, GERMANY

Scientific career

2015- Clinician-Scientist (Gerok) at the Post-Doc level in Project 6 “Role of the complement system and microglia in age-related macular degeneration” in the DFG Research Unit FOR 2240 “Angiogenesis, Lymphangiogenesis and Cellular Immunity in Inflammatory Diseases of the Eye” at the Department of Ophthalmology, University of Cologne

2018 Habilitation in the Department of Ophthalmology, University of Cologne

2018- Affiliated Clinician-Scientist at the Post-Doc level in Project 6 “The role of midkine in tumor-associated lymphangiogenesis and metastasis of ocular malignant melanoma” in the DFG Research Unit FOR 2240 “Angiogenesis, Lymphangiogenesis and Cellular Immunity in Inflammatory Diseases of the Eye” at the Department of Ophthalmology, University of Cologne

Prizes and honors

2016 Merit admission into the Cornelia Harte Mentoring (CHM) PRO program for advanced female scientists at the PhD, Post-Doc, and Habilitation levels with a career aim in science and research organized by the Personnel Development Unit, University of Cologne

Selected Publications

Schick T, Altay L, Viehweger E, Hoyng CB, den Hollander AI, Felsch M, Fauser S. Genetics of Unilateral and Bilateral Age-Related Macular Degeneration Severity Stages. PLoS One. 2016;11(6):e0156778.

Paun CC, Lechanteur YT, Groenewoud JM, Altay L, Schick T, Daha MR, Fauser S, Hoyng CB, den Hollander AI, de Jong EK. A Novel Complotype Combination Associates with Age-Related Macular Degeneration and High Complement Activation Levels in vivo. Sci Rep. 2016;6:26568.

Fritsche LG, Igl W, Bailey JN, …[+115]… Ersoy L, … [+42]… Heid IM. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016;48(2):134-43.

Ersoy L, Schick T, de Graft D, Felsch M, Hoyng CB, den Hollander AI, Kirchhof B, Fauser S, Liakopoulos S. Extramacular drusen are highly associated with age-related macular degeneration, but not with CFH and ARMS2 genotypes. Br J Ophthalmol. 2016;100(8):1047-51.

Schick T, Ersoy L, Hoyng CB, Kirchhof B, Liakopoulos S. Phenotype Characteristics of Fellow Eyes in Patients With Early Onset of Neovascular Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2015;56(12):7269-73.

Ersoy L, Ristau T, Lechanteur YT, Hahn M, Hoyng CB, Kirchhof B, den Hollander AI, Fauser S. Nutritional risk factors for age-related macular degeneration. Biomed Res Int. 2014;2014:413150.

Ristau T, Ersoy L, Hahn M, den Hollander AI, Kirchhof B, Liakopoulos S, Fauser S. Nongenetic risk factors for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2014;55(8):5228-32.

Caramoy A, Ristau T, Lechanteur YT, Ersoy L, Müller S, Gelisken F, Hoyng CB, Kirchhof B, den Hollander AI, Fauser S. Environmental and genetic risk factors for retinal angiomatous proliferation. Acta Ophthalmol. 2014;92(8):745-8.

Ersoy L, Ristau T, Hahn M, Karlstetter M, Langmann T, Dröge K, Caramoy A, den Hollander AI, Fauser S. Genetic and environmental risk factors for age-related macular degeneration in persons 90 years and older. Invest Ophthalmol Vis Sci.2014;55(3):1842-7.

Ersoy L, Ristau T, Kirchhof B, Liakopoulos S. Response to anti-VEGF therapy in patients with subretinal fluid and pigment epithelial detachment on spectral-domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2014;252(6):889-97.

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Claudia Bock
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
claudia.bock@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck
      Um unsere Website für Sie optimal zu gestalten und fortlaufend verbessern zu können, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Weitere Informationen zu Cookies und insb. der Möglichkeiten, der Verwendung von Cookies zu widersprechen, erhalten Sie in unserer Datenschutzerklärung.SchließenDatenschutzerklärung